Contact Us

Global Hormone Replacement Therapy Market to Surpass 7.22 Billion by 2023

Infinium Global Research has added a new report on Global Hormone Replacement Therapy Market: Trends Analysis and Forecast 2023.The report presents analysis of global as well as regional markets of Hormone replacement therapy over the period of 2015 to 2023. Moreover, the IGR-Growth Matrix given in the report provides key focus areas and investment areas the market players can focus on. The market size is presented in terms of value for the historic year 2015 and estimated for forecast period of 2017 to 2023.


Get 15% discount for early purchase of “Global Hormone Replacement Therapy Market by region (North America, Europe, Asia Pacific, Latin America and RoW)” report on


The global hormone replacement therapy market was dominated by the Americas region followed by the European market in 2015 and 2016. On the basis of countries, the U.S., led the global hormone replacement therapy market. Increasing in incidence of regularly monitored formulations, technological advancement in drug delivery systems, growing awareness among the patients, and Reformulation of permitted drugs drive the market globally. Injectable hormones need to be stored in cold conditions to preserve their efficiency, high cost of hormone replacement therapy treatment, and the side effect caused by hormonal replacement therapy are the key factors restraining the growth of this market.

Increasing frequencies of hormonal imbalance disorders and rising elderly population suffering from these diseases is projected to provide opportunities for the companies operating in the hormone replacement therapy market over the forecast period.

The report segments the global hormone replacement therapy market in terms of product types and applications. Among the product type the estrogen-replacement therapy accounted for the largest share over the period of 2015 and 2016.

The report provides competitive analysis of the leading companies in the hormone replacement therapy market including Amgen, Genentech, Novo Nordisk, Wyeth, Bayer, MED-EL, Eli Lily, Merck & Co., Mylan Laboratories, Pfizer and others.

Reasons to buy this report


1)    Comprehensive analysis of global as well as regional markets of Hormone replacement therapy

2)    Complete coverage of all the type and application segments to analyze the trends, developments, and forecast of market size up to 2023.

3)    Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4)    Infinium Global Research- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.


About Infinium Global Research

Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.

Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.

sign up for our newsletter